Instead of directly targetingcancer cells, our strategy targets macrophages and uses them as asecretory source of ATP and HMGB1 to enhance radiation-induced ICD.Our research introduces a new nanoparticle-based immunomodulatoryapproach that may have applications in radiotherapy and beyond. The gene discussed is HMGB1; the disease is impulse control disorder.